A New Drug Target for Type 2 Diabetes
- PMID: 28666114
- DOI: 10.1016/j.cell.2017.06.024
A New Drug Target for Type 2 Diabetes
Abstract
Genetic studies can identify novel therapeutic targets for common complex diseases. In this issue of Cell, Rusu et al. demonstrate that a cluster of genetic variants associated with an increased risk of type 2 diabetes affect the function of a monocarboxylate transporter involved in nutrient flux and hepatic lipid metabolism.
Copyright © 2017 Elsevier Inc. All rights reserved.
Comment on
-
Type 2 Diabetes Variants Disrupt Function of SLC16A11 through Two Distinct Mechanisms.Cell. 2017 Jun 29;170(1):199-212.e20. doi: 10.1016/j.cell.2017.06.011. Cell. 2017. PMID: 28666119 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical